More Research Needed on Use of Premium Cigars, Report Finds These cigars seem less dangerous than cigarettes -- but it's only because of how they are smoked Mar 10, 2022
Fecal Microbiome Markers Detect Pancreatic Cancer With 'High Accuracy' These markers need to be tested in a prospective cohort before clinical impact can be determined Mar 10, 2022
Robotic Hepatectomy Shows Benefits Over Laparoscopic Surgery Shorter hospital stay, similar perioperative outcomes in matched analysis Mar 10, 2022
Radioiodine for Low-Risk Thyroid Cancer: Yea or Nay? Randomized study finds no meaningful difference in events of abnormalities between groups Mar 09, 2022
Another Casualty of COVID-19: Evidence-Based Medicine Physician laments decline in research quality, critical appraisal during pandemic Mar 09, 2022
Androgen Receptor Agonist Active in Resistant ER+ Breast Cancer Also: Combination targets uncommon form of advanced HER2-mutant disease Mar 09, 2022
Is ctDNA Useful for Surveillance in Resected CRC? Small study suggests no advantage compared to imaging alone or with CEA measurement Mar 08, 2022
More Options for Precision Medicine in Metastatic Triple-Negative Breast Cancer Moving beyond chemotherapy to immunotherapy, PARP inhibitors, ADCs, combinations Mar 08, 2022
9/11 Responders More Likely to Carry Genetic Mutations Tied to Cancer Clonal hematopoiesis seen in 10% of firefighters, medical personnel on the scene after WTC attack Mar 07, 2022
Chipping Away at the Dogma of Axillary Dissection in Breast Cancer Ongoing trials could help some women avoid even less-invasive sentinel lymph node biopsy Mar 07, 2022
Clinical Picture Brightens for HER2+ Breast Cancer With Brain Metastases New therapies breach blood-brain barrier to improve response, survival Mar 07, 2022
Honing the Indications for Adjuvant CDK4/6 Inhibition in Breast Cancer Defining high risk, considering role of Ki-67, BRCA mutations Mar 05, 2022
Check Troponin in RCC Patients Before Checkpoint-VEGFR Inhibitor Combo In JAVELIN Renal 101, those with high levels had more heart events with avelumab-axitinib Mar 05, 2022
Cancer May Heighten Odds of Guillain-Barre Syndrome Link strongest with hematologic malignancies as well as prostate, breast, and respiratory cancers Mar 03, 2022
ARB-Cancer Link May Come Down to Cumulative Exposure Does a new paper resolve the conflicting safety data on the popular antihypertensives? Mar 02, 2022
Kids With IBD Need Close Monitoring as They Grow Up Meta-analysis confirms: substantially increased cancer risk in adulthood Mar 02, 2022
Novel Therapies Active in Head and Neck Cancers High response rate with oncolytic virus plus immunotherapy in cutaneous lesions Feb 28, 2022
AI Platform Near Perfect for Predicting Thyroid Malignancy High precision for T stage, extracapsular extension, BRAF mutation Feb 27, 2022
Merkel Cell Carcinoma Much More Likely to Recur vs Other Skin Cancers 5-year recurrence rate was 40% compared with 19% for melanoma Feb 23, 2022
PD-L1 Inhibitor Fails to Meet PFS Target in Advanced Penile Cancer Atezolizumab did show some activity, with a 30% overall response rate Feb 22, 2022
Enfortumab Vedotin Promising in Neovadjuvant Therapy in Advanced Bladder Cancer Early-phase study offers 36% pCR in cisplatin-ineligible patients with muscle-invasive disease Feb 19, 2022
Enzalutamide Rechallenge Yields Small PFS Boost in Metastatic Prostate Cancer Docetaxel-enzalutamide regimen may offer another option for men who progressed on AR inhibitor Feb 18, 2022
Two PARP Inhibitors Impress as First-Line Add-Ons in mCRPC In one case, rPFS benefit was seen regardless of HRR mutational status Feb 18, 2022
Ablating High-Grade Anal Lesions Thwarts Progression to Cancer Screening followed by aggressive therapy shows benefit in phase III ANCHOR study Feb 17, 2022
Darolutamide Improves OS in Metastatic Prostate Cancer The AR inhibitor plus standard therapy led to a 32% reduced risk of death versus placebo Feb 17, 2022
Early Clinical Activity With CDK4/6 Inhibitor in Pretreated Mesothelioma Disease control in 54% of patients in first clinical evaluation of abemaciclib Feb 17, 2022
Sotorasib Impresses in Advanced Pancreatic Cancer ORR of 21% in heavily pretreated patients with a KRAS G12C mutation Feb 16, 2022
Third Person 'Cured' of HIV via Transplant U.S. woman with leukemia gets cord blood resistant to HIV Feb 16, 2022
Long-Term Survival Benefit in NSCLC With Another Anti-PD-1/L1 Drug Significant improvements in OS, PFS with durvalumab after CRT for unresectable disease Feb 15, 2022
Women More Likely to Experience Severe Toxicity of Cancer Treatments Increased risk was particularly pronounced among those receiving immunotherapy Feb 14, 2022
Pembrolizumab Shows Promise in Advanced Anal Cancer PD-1 inhibitor may be an option for those who have no options Feb 11, 2022
Active Cellular Immunotherapy Disappoints in Metastatic Prostate Cancer In combination with chemotherapy, no OS benefit seen with DCVAC/PCa over placebo Feb 10, 2022
Illusionist Criss Angel's Son's Acute Leukemia Famed magician speaks about the long battle Feb 09, 2022
Uterine Cancer Mortality Now Neck and Neck With Ovarian Cancer Advances in ovarian cancer, stagnation in uterine cancer, and "alarming" racial disparity Feb 09, 2022
Did Improved Treatment for Cervical Abnormalities Affect Birth Outcomes? Swedish data found risks for adverse outcomes remain higher, but declined over time Feb 07, 2022
Dear Blood Donors, You've Given Me the Gift of Life I offer my gratitude through acceptance, acknowledgement, and reflection Feb 06, 2022
FDA Concerned About Safety of Lymphoma Drug Hint of excess mortality in trial of umbralisib/ublituximab prompts public notice Feb 03, 2022
Genetic Role of Alcohol-Cancer Link Strengthened In study from China, two common variants associated with lower risk of cancer in men Feb 01, 2022
When Strangers Deliver Bad News to Patients All too often, I end up giving prognoses to patients I barely know Jan 31, 2022
Dual HER2 Therapy Active in Previously Treated Lung Cancer Disease control in 87% of HER2-mutant NSCLC treated with trastuzumab, pertuzumab, docetaxel Jan 27, 2022
